Safety and Efficacy of Prophylactic Arterial Embolization in the Treatment of Angiography-negativ… (NCT05550649) | Clinical Trial Compass
UnknownNot Applicable
Safety and Efficacy of Prophylactic Arterial Embolization in the Treatment of Angiography-negative Acute Upper Gastrointestinal Bleeding
China60 participantsStarted 2022-09-30
Plain-language summary
Guided by clinical problems, this study focused on the problems encountered in clinical practice, with the interventional treatment of emergency gastrointestinal bleeding as the breakthrough point, and focused on the dilemma of treatment selection for patients with negative angiography in gastrointestinal bleeding. At present, there is no report on relevant clinical and basic research on the selection of treatment strategies for patients with negative ANVUGIB angiography. Whether prophylactic arterial embolization can benefit patients and whether it can reduce mortality is an urgent clinical problem to be solved.
Who can participate
Age range16 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age: 18\~75 years old (including 18 years old and 75 years old);
✓. Bleeding of gastric or duodenal ulcers that have failed endoscopic therapy;
✓. Anastomotic bleeding after gastrointestinal anastomosis;
✓. Anastomotic bleeding after cholangioenterostomy;
✓. Bleeding after ERCP;
✓. There were no indirect signs of contrast agent spillage and bleeding in angiography.
Exclusion criteria
✕. Age: \<18 years old or \>75 years old;
✕. Rupture and bleeding of gastric fundus esophageal varices;
✕. Active bleeding can be seen on angiography;
✕. Upper gastrointestinal bleeding caused by other causes other than the inclusion criteria;